InCube Labs, L.L.C. - 03 Feb 2022 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role: 10%+ Owner
Signature: /s/ Josh Seidenfeld, Attorney-in-Fact for Mir Imran, President of InCube Labs, LLC
Issuer symbol: RANI
Transactions as of: 03 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 07 Feb 2022, 20:36:59 UTC
Previous filing: 02 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RANI	Class A Common Stock	Other	$0	+13,923		$0.000000	13,923	03 Feb 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Received in kind pro rata distribution from Biologix Partners, LP (3,181 shares of Class A Common Stock) and VH Rani, LP. (10,742 shares of Class A Common Stock), to its limited partners.